Related references
Note: Only part of the references are listed.KLF10 loss in the pancreas provokes activation of SDF-1 and induces distant metastases of pancreatic ductal adenocarcinoma in the KrasG12D p53flox/flox model
C-C Weng et al.
ONCOGENE (2017)
Pancreatic Tumor Progression Associated With CD133 Overexpression Involvement of Increased TERT Expression and Epidermal Growth Factor Receptor-Dependent Akt Activation
Ching-Chieh Weng et al.
PANCREAS (2016)
Cancer Stem Cell Marker Phenotypes Are Reversible and Functionally Homogeneous in a Preclinical Model of Pancreatic Cancer
Joseph S. Dosch et al.
CANCER RESEARCH (2015)
Integrative Clinical Genomics of Advanced Prostate Cancer
Dan Robinson et al.
CELL (2015)
Targeted Next-generation Sequencing of Advanced Prostate Cancer Identifies Potential Therapeutic Targets and Disease Heterogeneity
Himisha Beltran et al.
EUROPEAN UROLOGY (2013)
Coptisine inhibits RANKL-induced NF-κB phosphorylation in osteoclast precursors and suppresses function through the regulation of RANKL and OPG gene expression in osteoblastic cells
Ji-Won Lee et al.
JOURNAL OF NATURAL MEDICINES (2012)
Combined point mutations in codon 12 and 13 of KRAS oncogene in prostate carcinomas
Fatma Silan et al.
MOLECULAR BIOLOGY REPORTS (2012)
CD24 expression is important in male urothelial tumorigenesis and metastasis in mice and is androgen regulated
Jonathan B. Overdevest et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)
Bone metastasis in prostate cancer: emerging therapeutic strategies
Justin Sturge et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2011)
Dickkopf-1 (DKK-1) Stimulated Prostate Cancer Growth and Metastasis and Inhibited Bone Formation in Osteoblastic Bone Metastases
Nanda K. Thudi et al.
PROSTATE (2011)
Cancer to bone: a fatal attraction
Katherine N. Weilbaecher et al.
NATURE REVIEWS CANCER (2011)
RAF inhibitors prime wild-type RAF to activate the MAPK pathway and enhance growth
Georgia Hatzivassiliou et al.
NATURE (2010)
CD24+ cells from hierarchically organized ovarian cancer are enriched in cancer stem cells
M-Q Gao et al.
ONCOGENE (2010)
PI3K Pathway Activation Mediates Resistance to MEK Inhibitors in KRAS Mutant Cancers
Susan Wee et al.
CANCER RESEARCH (2009)
CD24 Is a Novel Predictor for Poor Prognosis of Hepatocellular Carcinoma after Surgery
Xin-Rong Yang et al.
CLINICAL CANCER RESEARCH (2009)
Claudin-7 Regulates EpCAM-Mediated Functions in Tumor Progression
Tobias Nuebel et al.
MOLECULAR CANCER RESEARCH (2009)
Nuclear signalling by tumour-associated antigen EpCAM
Dorothea Maetzel et al.
NATURE CELL BIOLOGY (2009)
On the abundance of EpCAM on cancer stem cells
Olivier Gires et al.
NATURE REVIEWS CANCER (2009)
Targeting CD24 for treatment of colorectal and pancreatic cancer by monoclonal antibodies or small interfering RNA
Eyal Sagiv et al.
CANCER RESEARCH (2008)
Prostate cancer induces bone metastasis through Wnt-induced bone morphogenetic protein-dependent and independent mechanisms
Jinlu Dai et al.
CANCER RESEARCH (2008)
BRAF Activation Initiates but Does Not Maintain Invasive Prostate Adenocarcinoma
Joseph H. Jeong et al.
PLOS ONE (2008)
Characterization of the novel P-selectin inhibitor PSI-697 [2-(4-chlorobenzyl)-3-hydroxy-7,8,9,10-tetrahydrobenzo[h] quinoline-4-carboxylic acid] in vitro and in rodent models of vascular inflammation and thrombosis
Patricia W. Bedard et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2008)
Patterns of somatic mutation in human cancer genomes
Christopher Greenman et al.
NATURE (2007)
Identification of putative stem cell markers, CD133 and CXCR4, in hTERT-immortalized primary nonmalignant and malignant tumor-derived human prostate epithelial cell lines and in prostate cancer specimens
Jun Miki et al.
CANCER RESEARCH (2007)
Prevalent mutations in prostate cancer
JT Dong
JOURNAL OF CELLULAR BIOCHEMISTRY (2006)
Pten deletion leads to the expansion of a prostatic stem/progenitor cell subpopulation and tumor initiation
SY Wang et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
BRAF mutation predicts sensitivity to MEK inhibition
DB Solit et al.
NATURE (2006)
Target of rapamycin (TOR): an integrator of nutrient and growth factor signals and coordinator of cell growth and cell cycle progression
DC Fingar et al.
ONCOGENE (2004)
CD24 expression is a significant predictor of PSA relapse and poor prognosis in low grade or organ confined prostate cancer
G Kristiansen et al.
PROSTATE (2004)
Cooperative regulation of the cell division cycle by the protein kinases RAF and AKT
AM Mirza et al.
MOLECULAR AND CELLULAR BIOLOGY (2004)
Transgenic mouse with high Cre recombinase activity in all prostate lobes, seminal vesicle, and ductus deferens
CL Jin et al.
PROSTATE (2003)
Clinical utility of the percentage of positive prostate biopsies in predicting prostate cancer-specific and overall survival after radiotherapy for patients with localized prostate cancer
AV D'Amico et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2002)
Prostate stem cell antigen (PSCA) expression increases with high gleason score, advanced stage and bone metastasis in prostate cancer
Z Gu et al.
ONCOGENE (2000)
Share Paper
